GENETIC POLYMORPHISMS OF VKORC1, CYP2C9, CYP4F2 IN BAI-, ZANG-CHINESE

被引：0
|
作者：
Tao, Ceng Wu [1 ]
机构：
[1] Zhongshan Med Univ, Affiliated Hosp 1, Zhongshan, Peoples R China
来源：
HEART | 2011年 / 97卷
关键词：
D O I：
10.1136/heartjnl-2011-300867.332
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genetic polymorphisms of VKORC1, CYP2C9, CYP4F2 in Bai, Tibetan Chinese
    Zeng, W. T.
    Zheng, Q. S.
    Huang, M.
    Cen, H. J.
    Lai, Y.
    Chen, W. Y.
    Zhao, L. Z.
    Leng, X. Y.
    [J]. PHARMAZIE, 2012, 67 (01): : 69 - 73
  • [2] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    [J]. BLOOD, 2012, 120 (21)
  • [3] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes
    Teichert, Martina
    Eijgelsheim, Mark
    Uitterlinden, Andre G.
    Buhre, Peter N.
    Hofman, Albert
    De Smet, Peter A. G. M.
    Visser, Loes E.
    Stricker, Bruno H. Ch.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 26 - 34
  • [4] Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes
    Kalpana, S. R.
    Bharath, G.
    Jain, Simran
    Moorthy, Nagaraja
    Manjunath, Satvic C.
    Christopher, Rita
    [J]. MEDICINE, 2019, 98 (06)
  • [5] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    Sambyalova, A. Yu.
    Bairova, T. A.
    Belyaeva, E. V.
    Ershova, O. A.
    Sargaeva, D. S.
    Kolesnikov, S. I.
    [J]. RUSSIAN JOURNAL OF GENETICS, 2020, 56 (12) : 1496 - 1503
  • [6] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    A. Yu. Sambyalova
    T. A. Bairova
    E. V. Belyaeva
    O. A. Ershova
    D. S. Sargaeva
    S. I. Kolesnikov
    [J]. Russian Journal of Genetics, 2020, 56 : 1496 - 1503
  • [7] The Frequency of CYP2C9, VKORC1, and CYP4F2 Polymorphisms in Russian Patients With High Thrombotic Risk
    Ivashchenko, Dmitriy
    Rusin, Ilya
    Sychev, Dmitriy
    Grachev, Audrey
    [J]. MEDICINA-LITHUANIA, 2013, 49 (12): : 517 - 521
  • [8] Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients
    Zhuang, Wenfang
    Wen, Wei
    Xuan, Binbin
    Chen, Yanhong
    Cao, Yanan
    Sun, Zhixin
    Ma, Jun
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (02) : 167 - 174
  • [9] Impact of VKORC1, CYP2C9, and CYP4F2 Polymorphisms on Optimal Warfarin Dose: Does Ethnicity Matters?
    Li, Jia X.
    Kim, Moo H.
    Song, Kai
    Guo, Long Z.
    Jin, En Z.
    Kim, Soo J.
    Lee, Kwang M.
    Serebruany, Victor
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E461 - E468
  • [10] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
12345